Related Experiment Video
Updated: Apr 27, 2026

A Modified Surgical Technique for Kidney Transplantation in Mice
Published on: July 22, 2022
Subcutaneous nephrovesical bypass in kidney transplanted patients
M Yazdani1, M R Gharaati2, M Zargham1
1Department of Urology and Renal Transplantation, Isfahan University of Medical Sciences, Isfahan, Iran.
Subcutaneous prosthetic ureters offer a safe alternative for kidney transplant recipients experiencing recurrent ureteral obstruction after other surgeries fail. This salvage procedure effectively manages ureteral stenosis, avoiding permanent percutaneous nephrostomy.
Area of Science:
- Urology
- Transplant Surgery
- Medical Devices
Background:
- Renal transplant ureteral stricture/obstruction is a rare but severe complication.
- Recurrent ureteral obstruction poses significant challenges in kidney transplant recipients.
Purpose of the Study:
- To evaluate the efficacy and safety of subcutaneous prosthetic ureters.
- To assess this salvage procedure for transplanted kidneys with recurrent ureteral obstruction.
Main Methods:
- Five patients with recurrent ureteral stenosis underwent implantation of subcutaneous prosthetic ureters.
- The prosthetic ureter involved a silicone tube within a PTFE coil, placed via a subcutaneous tunnel.
- The procedure included percutaneous insertion into the kidney and suprapubic insertion into the bladder.
Main Results:
- Mean follow-up was 11.3 months.
- One patient required reoperation for distal urinary leakage.
- No instances of infection or tube encrustation were observed.
Conclusions:
- Subcutaneous prosthetic ureters provide a viable alternative to permanent percutaneous nephrostomy.
- This method is effective for transplanted kidneys with ureteral obstruction unresponsive to prior interventions.
Related Concept Videos
Kidney Transplant II: Surgical Procedure
Kidney Transplant I: Introduction
Imaging Studies V: Intravenous Urography and Retrograde Pyelography
Kidney Transplant III: Nursing Management
Urinary Tract Calculi VI: Surgical Management
Extracorporeal Removal of Drugs: Continuous Renal Replacement Therapy

